Patient Insights on Acne Hyperpigmentation, Trifarotene, and Skincare: 6-Month, LEAP Phase 4 Qualitative Exit Interview Findings.
Saved in:
| Title: | Patient Insights on Acne Hyperpigmentation, Trifarotene, and Skincare: 6-Month, LEAP Phase 4 Qualitative Exit Interview Findings. |
|---|---|
| Authors: | Dias-Barbosa C; PPD Evidera Patient Centered Research, part of Thermo Fisher Scientific, London, UK. Carla.Dias-Barbosa@thermofisher.com., Taylor N; PPD Evidera Patient Centered Research, part of Thermo Fisher Scientific, Wilmington, USA., Chan K; Galderma Laboratories, Dallas, TX, USA., York JP; Galderma Laboratories, Dallas, TX, USA., Puelles J; Galderma, Zug, Switzerland., Chavda R; Galderma, Lausanne, Switzerland. |
| Source: | The patient [Patient] 2026 Mar; Vol. 19 (2), pp. 343-352. Date of Electronic Publication: 2025 Nov 24. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase IV; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101309314 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1178-1661 (Electronic) Linking ISSN: 11781653 NLM ISO Abbreviation: Patient Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1178-1661 |
|---|---|
| DOI: | 10.1007/s40271-025-00789-9 |
